I think it is safe to say that the reviews will be fantastic....

I think it is safe to say that the reviews will be fantastic.
Advanced biomarkers, clinical validation and accuracy, dual blood pressure measurement.App- making the numbers understandable.
What would a negative review look like? Would be small nuances.
What other BPM on the market has these features. Who would choose anything else , except for price point which is a factor.

I personally think the market is asleep to what is offered here. Disruption , best in class.
What would Omron be thinking that there range of BPM are no longer as relevant and possibly become extinct over the next few years. Are other companies in this area taking notice.

I predict a announcement or deal will occur and all of a sudden the limited perception most investors have will gain the perspective many of us see .



.